Proteus and Otsuka expect to hear back from the FDA by Q4 of this year. Assuming the approval goes through, Otsuka could begin selling the drug shortly thereafter. Subsequent approvals of embedded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback